esophageal adenocarcinoma
Study Links Severity of Obesity to Elevated Risk for BE and Esophageal Cancer
The risk of developing BE and EAC increases with severity of obesity, according to a new study presented at DDW ...
JULY 14, 2025
FDA Approves Opdivo Qvantig for Subcutaneous Injection
The FDA approved nivolumab plus hyaluronidase-nvhy (Opdivo Qvantig, Bristol Myers Squibb) for subcutaneous ...
DECEMBER 30, 2024
Guideline Change for Resectable Esophageal Cancer?
Chemotherapy before and after surgery for locally advanced esophageal adenocarcinoma—the FLOT ...
JULY 19, 2024
Nonerosive GERD Did Not Increase Esophageal Ca Risk in Nordic Nations
Patients diagnosed with nonerosive gastroesophageal reflux disease did not have a higher incidence of esophageal ...
FEBRUARY 23, 2024
Opdivo Approved for First-Line Treatment of Advanced or Metastatic GI Cancers
The FDA approved nivolumab (Opdivo, Bristol Myers Squibb), in combination with fluoropyrimidine- and ...
APRIL 27, 2021
Negative Margins More Likely With Surgical Resection in Treatment of Esophageal Tumors
To ensure a negative surgical margin in treating T1b esophageal adenocarcinoma, perform the resection surgically, ...
FEBRUARY 5, 2020
